Technologies

Will Putin Prevent Rebrikov from Attempting Heritable Genome Editing?

By Pete Shanks | 10.08.2019
Biopolitical Times
The Russian molecular biologist who wants to edit the genomes of human embryos is getting impatient with authorities who won't yet let him go ahead.
Policies

U.S. Government Plans to Collect DNA from Detained Immigrants

By Caitlin Dickerson, The New York Times | 10.02.2019

Aggregated News

The Department of Homeland Security said it would begin collecting genetic data on hundreds of thousands of immigrants in federal detention facilities.
Genomics

Despite Calls for a Moratorium, More ‘Three-Parent’ Babies Expected Soon

By Emily Mullin, One Zero | 09.16.2019

Aggregated News

At least 10 babies have been born to apparently infertile women as a result of a controversial in vitro fertilization...

Assisted Reproduction
tree logo of The Hastings Center

Reproductive Embryo Editing: Attending to Justice

By Inmaculada De Melo-Martín, The Hastings Center Report | 08.22.2022

Aggregated News

Society
a dna helix with some tweezers

Thence We Will Create Superhumans

By Corinne Othenin-Girard, Philosophical Investigations | 08.22.2022

Aggregated News

Genetic Selection
man with bionic arm

The Bionic-Hand Arms Race

By Britt H. Young, IEEE Spectrum | 08.21.2022

Aggregated News

Perspectives
A Tasmanian tiger

The Guardian view on de-extinction: Jurassic Park may be becoming reality

By Editorial, The Guardian | 08.19.2022

Aggregated News

Animal Biotechnologies
a gavel next to a gold plaque that says "patent law"

New Bill Would Bring Back Terrible Software and Genetic Patents

By Joe Mullin, Electronic Frontier Foundation | 08.18.2022

Aggregated News

Genomics

The ‘Perfect’ Baby?: The Dangers of Gene Editing in Assisted Reproduction

By Daisy Boyd | 08.18.2022
Biopolitical Times
Assisted Reproduction
a golden dna strand

New Method Improves Speed and Cost of Birth Defect Testing

By Gina Kolata, The New York Times | 08.17.2022

Aggregated News

Assisted Reproduction
the official FDA building with a sign in front

FDA approves one of the priciest new treatments of all time — bluebird's gene therapy for beta thalassemia

By Zachary Brennan, Endpoints News | 08.17.2022

Aggregated News

Genomics